Brief: Bonesupport Says FDA Notification Approval On Denovo Pathway For Cerament G Will Require Additional Data And Clarifications

BoneSupport Holding AB

27/02/2021 13:34

Feb 27 (Reuters) - Bonesupport Holding AB  BONEX.ST :
    * BONESUPPORT'S FDA NOTIFICATION: APPROVAL ON DENOVO PATHWAY
FOR
CERAMENT G WILL REQUIRE ADDITIONAL DATA AND CLARIFICATIONS
    * WILL WORK TO ACCOMMODATE REQUESTS BY FDA
    * REVISED TIMING FOR POTENTIAL DENOVO APPROVAL FOR
INDICATION BONE
INFECTIONS IS ESTIMATED FOR Q1 2022

Source text for Eikon:  ID:nWkr9ngVB1 
Further company coverage:  BONEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))